Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era.

Literature DB >> 30389726

Persistent Underrepresentation of Kidney Disease in Randomized, Controlled Trials of Cardiovascular Disease in the Contemporary Era.

Rohit Maini¹, David B Wong², Daniel Addison^3,4,5, Elizabeth Chiang⁶, Steven D Weisbord⁷, Hani Jneid^8,9.

Abstract

Entities: Disease

Keywords: cardiovascular; cardiovascular disease; chronic kidney disease; chronic renal disease; randomized controlled trials

Mesh：

Substances：

Year: 2018 PMID： 30389726 PMCID： PMC6287860 DOI： 10.1681/ASN.2018070674

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

10 in total

Review 1. Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review.

Authors: Ioannis Konstantinidis; Girish N Nadkarni; Rabi Yacoub; Aparna Saha; Priya Simoes; Chirag R Parikh; Steven G Coca
Journal: JAMA Intern Med Date: 2016-01 Impact factor: 21.873

2. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal: Circulation Date: 2013-06-05 Impact factor: 29.690

3. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors: Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Jacqueline E Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal: Circulation Date: 2012-12-17 Impact factor: 29.690

4. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: Circulation Date: 2014-03-28 Impact factor: 29.690

5. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors: Ezra A Amsterdam; Nanette K Wenger; Ralph G Brindis; Donald E Casey; Theodore G Ganiats; David R Holmes; Allan S Jaffe; Hani Jneid; Rosemary F Kelly; Michael C Kontos; Glenn N Levine; Philip R Liebson; Debabrata Mukherjee; Eric D Peterson; Marc S Sabatine; Richard W Smalling; Susan J Zieman
Journal: Circulation Date: 2014-09-23 Impact factor: 29.690

6. Deaths: Final Data for 2013.

Authors: Jiaquan Xu; Sherry L Murphy; Kenneth D Kochanek; Brigham A Bastian
Journal: Natl Vital Stat Rep Date: 2016-02-16

7. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease.

Authors: D Charytan; R E Kuntz
Journal: Kidney Int Date: 2006-10-18 Impact factor: 10.612

Review 8. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors: Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal: JAMA Date: 2006-09-20 Impact factor: 56.272

9. Ventricular Arrhythmia Burden in Patients With Heart Failure and Cardiac Resynchronization Devices: The Importance of Renal Function.

Authors: Girish Ganesha Babu; Matthew Webber; Rui Providencia; Sanjeev Kumar; Aerakondal Gopalamurugan; Dominic P Rogers; Holly Louise Daw; Syed Ahsan; Fakhar Khan; Anthony Chow; Martin Lowe; Edward Rowland; Pier Lambiase; Oliver R Segal
Journal: J Cardiovasc Electrophysiol Date: 2016-10-06

10. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.

Authors: William M McClellan; Robert D Langston; Rodney Presley
Journal: J Am Soc Nephrol Date: 2004-07 Impact factor: 10.121

10 in total

14 in total

1. Generalizability of SPRINT-CKD cohort to CKD patients referred to renal clinics.

Authors: Roberto Minutolo; Luca De Nicola; Ciro Gallo; Paolo Chiodini; Michele Provenzano; Giuseppe Conte; Carlo Garofalo; Silvio Borrelli
Journal: J Nephrol Date: 2019-01-23 Impact factor: 3.902

2. Exclusion of Persons with Kidney Disease in Trials of Peripheral Artery Disease: A Systematic Review of Randomized Trials.

Authors: Yumeng Wen; O Alison Potok; Xin Wei; Ishan Paranjpe; Lili Chan; Rakesh Malhotra; Steven Coca; Jagat Narula; Jeffrey W Olin; Girish N Nadkarni; Pranav S Garimella
Journal: Clin J Am Soc Nephrol Date: 2019-12-30 Impact factor: 8.237

Review 3. An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turning.

Authors: Cong Ying Hey; Sérgio Barra; Rudolf Duehmke; Stephen Pettit; Wayne C Levy; José Silva-Cardoso; Rui Providência
Journal: Heart Fail Rev Date: 2022-02-07 Impact factor: 4.654

4. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.

Authors: Yusuke Uemura; Shinji Ishikawa; Kenji Takemoto; Yosuke Negishi; Akihito Tanaka; Kensuke Takagi; Naoyuki Yoshioka; Norio Umemoto; Yosuke Inoue; Itsuro Morishima; Naoki Shibata; Hiroshi Asano; Hideki Ishii; Masato Watarai; Toyoaki Murohara
Journal: Clin Exp Nephrol Date: 2020-01-06 Impact factor: 2.801

5. Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.

Authors: Julie H Ishida; Cynthia Chauhan; Barbara Gillespie; Ken Gruchalla; Peter A McCullough; Susan Quella; Alain Romero; Patrick Rossignol; David C Wheeler; Meaghan A Malley; Melissa West; Charles A Herzog
Journal: Clin J Am Soc Nephrol Date: 2021-04-23 Impact factor: 10.614

6. The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Society of Nephrology and the Spanish Society of Cardiology.

Authors: Alberto Ortiz; Juan F Navarro-González; Julio Núñez; Rafael de la Espriella; Marta Cobo; Rafael Santamaría; Patricia de Sequera; Javier Díez
Journal: Clin Kidney J Date: 2021-12-23

7. Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Authors: Nita A Limdi; Timothy Mark Beasley; Jielin Sun; Norman Stockbridge; Michael Pacanowski; Jeffry Florian
Journal: Clin Pharmacol Ther Date: 2021-01-19 Impact factor: 6.903